Wilkinson Peter J
SVP, Chief Accounting Officer at LH; VP of Fin./Chief Acctg. Off. at PHARMACEUTICAL PRODUCT DEVELOPMENT INC
- Sold, on record
- $4M
- Dollars the filings state
- Form 4 sales
- 13
- Latest Aug 3, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- LHLABCORP HOLDINGS INC.SVP, Chief Accounting Officer
- PHARMACEUTICAL PRODUCT DEVELOPMENT INCVP of Fin./Chief Acctg. Off.
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- LH15,176 shares
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC7,287 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale LHUnusualNov 16, 2023 2023
Sold 1,384 shares at $210.71 ($292k)
Wilkinson Peter J, SVP, Chief Accounting Officer
No 10b5-1 planSold 39.9% of holdings ($731k position)2,087 shares leftFiling
- 2 Form 4 sale LHUnusualApr 29, 2024 +165 days
Sold 2,439 shares at $204.33 ($498k)
Wilkinson Peter J, SVP, Chief Accounting Officer
No 10b5-1 planSold 53.9% of holdings ($925k position)2,087 shares leftFiling
- 3 Form 4 sale LHUnusualFeb 18, 2025 +295 days
Sold 1,413 shares at $246.10 ($348k)
Wilkinson Peter J, SVP, Chief Accounting Officer
No 10b5-1 planSold 41.5% of holdings ($838k position)1,993 shares leftFiling
- 4 Form 4 sale LHUnusualMay 1, 2025 +72 days
Sold 829 shares at $242.27 ($201k)
Wilkinson Peter J, SVP, Chief Accounting Officer
No 10b5-1 planSold 28.8% of holdings ($699k position)2,054 shares left0.6x usual sizeFiling
- 5 Form 4 sale LHNo planJul 29, 2025 +89 days
Sold 202 shares at $261.02 ($53k)
Wilkinson Peter J, SVP, Chief Accounting Officer
No 10b5-1 planSold 9.8% of holdings ($536k position)1,852 shares left0.1x usual sizeFiling
- 6 Form 4 sale LHRoutineFeb 19, 2026 +205 days
Sold 666 shares at $277.94 ($185k)
Wilkinson Peter J, SVP, Chief Accounting Officer
10b5-1 planSold 26.4% of holdings ($700k position)1,852 shares left0.6x usual sizeFiling
- 7 Form 4 sale LHRoutineMar 27, 2026 +36 days
Sold 1,633 shares at $267.05 ($436k)
Wilkinson Peter J, SVP, Chief Accounting Officer
10b5-1 planSold 46.9% of holdings ($931k position)1,852 shares left2x usual sizeFiling
- 8 Form 4 sale LHUnusualAug 3, 2026 +129 days
Sold 1,420 shares at $309.23 ($439k)
Wilkinson Peter J, SVP, Chief Accounting Officer
No 10b5-1 planSold 44.5% of holdings ($987k position)1,770 shares left1.7x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (13)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | Aug 5, 2026 | LH | SVP, Chief Accounting Officer | Form 4 sale | 1,420 | $439k | 44.5% | Unusual | SEC |
| Mar 27, 2026 | Mar 30, 2026 | LH | SVP, Chief Accounting Officer | Form 4 sale | 1,633 | $436k | 46.9% | Routine | SEC |
| Feb 19, 2026 | Feb 23, 2026 | LH | SVP, Chief Accounting Officer | Form 4 sale | 666 | $185k | 26.4% | Routine | SEC |
| Jul 29, 2025 | Jul 31, 2025 | LH | SVP, Chief Accounting Officer | Form 4 sale | 202 | $53k | 9.8% | No plan | SEC |
| May 1, 2025 | May 5, 2025 | LH | SVP, Chief Accounting Officer | Form 4 sale | 829 | $201k | 28.8% | Unusual | SEC |
| Feb 18, 2025 | Feb 20, 2025 | LH | SVP, Chief Accounting Officer | Form 4 sale | 1,413 | $348k | 41.5% | Unusual | SEC |
| Apr 29, 2024 | May 1, 2024 | LH | SVP, Chief Accounting Officer | Form 4 sale | 2,439 | $498k | 53.9% | Unusual | SEC |
| Nov 16, 2023 | Nov 20, 2023 | LH | SVP, Chief Accounting Officer | Form 4 sale | 1,384 | $292k | 39.9% | Unusual | SEC |
| Aug 1, 2022 | Aug 3, 2022 | LH | SVP, Chief Accounting Officer | Form 4 sale | 2,576 | $666k | 57.7% | Unusual | SEC |
| Feb 18, 2021 | Feb 19, 2021 | LH | SVP, Chief Accounting Officer | Form 4 sale | 2,317 | $560k | 87.1% | Unusual | SEC |
| Feb 21, 2020 | Feb 25, 2020 | LH | SVP, Chief Accounting Officer | Form 4 sale | 297 | $56k | 50.0% | Unusual | SEC |
| Nov 27, 2007 | Nov 28, 2007 | PHARMACEUTICAL PRODUCT DEVELOPMENT INC | VP of Fin./Chief Acctg. Off. | Form 4 sale | 6,000 | $252k | 100.0% | Unusual | SEC |
| Aug 17, 2007 | Aug 17, 2007 | PHARMACEUTICAL PRODUCT DEVELOPMENT INC | VP of Fin./Chief Acctg. Off. | Form 4 sale | 1,287 | $47k | 100.0% | Unusual | SEC |